Vertosa facing some challenges

1 Like

For anyone concerned whether their hemp-derived materials are indeed derived from hemp, we have test methods that can identify and quantify the byproducts of the conversions used. When THC is isomerized from CBD, any residual CBDV will convert to THCV, too.

4 Likes

Based on the links above, what do you think is going on here?

I’m seeing an argument based on the presence of THCV and the absence of CBDV.

Almost all CBD isolate in the market has some amount of CBDV, usually below 1%. The same can be said about CBD distillate, it contains CBDV at higher concentrations.

When CBD is isomerized to D9-THC and then to D8-THC, the CBDV will isomerize to D9-THCV and then to D8-THCV.

Unless I’m missing more to the argument then it is entirely possible so-called hemp-derived D9-THC and D8-THC, both resultants from CBD isomerization, will contain D9-THCV and D8-THCV, respectively, in the absence of CBDV because it converted, too.

2 Likes

I posted the exhibit with the test results here(1-6.pdf)

the minor profile looks like normal type 1 derived THC distillate

2 Likes

Thanks for sharing, I only saw those documents posted at the top of the page, so I was missing more to the argument.

I agree with you.

3 Likes

The plot thickens. The plaintiff holds a patent on conversion from CBD to THC.

Yup multiple

So the way I interpret it is if they prove that it came from CBD isolate, they are in violation of the patents. LOL

1 Like

And if they didn’t, and it was normal cd9, then they could lose on the unfair competition claim

I don’t think that the patents are the big issue here, but I guess they could play that card later

1 Like

Im just a stoner. But I notice all the labels from legal weed say that it is 25 percent thc a and .3 or so delta 9. Are those labels all fake? Everything is wrong but delta 9 was supposedly the thing that got you high???